Durvalumab, Tremelimumab and Hypofractionated Radiation Therapy in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03522584 · TERMINATED
Trial details
- NCT number
- NCT03522584
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2021-12-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.